His clinical interests are in lymphomas and leukemias, and his research interests are in BCL-2 protein family regulation of apoptosis. He is returning to Yale, where he was an undergraduate, having completed his medical degree and PhD at Harvard Medical School, followed by a residency in pathology and fellowship in hematopathology at Brigham & Women’s Hospital.